Detalhe da pesquisa
1.
Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
J Virol
; 98(3): e0183823, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426726
2.
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
mBio
; 15(1): e0247723, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054729
3.
De novo antibody discovery in human blood from full-length single B cell transcriptomics and matching haplotyped-resolved germline assemblies.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585716
4.
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities.
Front Immunol
; 15: 1382619, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779671
5.
A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cells.
bioRxiv
; 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746439
6.
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.
bioRxiv
; 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131698
7.
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesis.
bioRxiv
; 2023 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817940
8.
Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus.
Nat Microbiol
; 8(6): 1108-1122, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142773
9.
Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model.
mSphere
; 7(1): e0088321, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107336
10.
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.
Lancet Reg Health Am
; 6: 100123, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841388
11.
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
Med
; 3(10): 705-721.e11, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044897
12.
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Res Sq
; 2021 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851150
13.
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
medRxiv
; 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821288
14.
Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals.
medRxiv
; 2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031663
15.
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals.
Front Immunol
; 12: 759688, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987505
16.
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Nat Commun
; 12(1): 4598, 2021 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312390
17.
Zoonotic potential of a novel bat morbillivirus.
Res Sq
; 2021 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611656
18.
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
mBio
; 12(1)2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593976
19.
Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera.
medRxiv
; 2020 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817961